{"title":"Non-contrast CT attenuation value of renal papilla is a novel predictor of recurrence in kidney stone disease.","authors":"Yasuo Kohjimoto, Shimpei Yamashita, Yuya Iwahashi, Ryusuke Deguchi, Takahito Wakamiya, Isao Hara","doi":"10.1186/s12894-024-01657-8","DOIUrl":null,"url":null,"abstract":"<p><p>In calcium stone formers, most stones grow attached to Randall's plaque, which can be identified by measuring the computed tomography (CT) attenuation value of renal papilla. We hypothesized that the CT attenuation value of renal papilla can predict the severity (recurrent or multiple stone former) and recurrence of the stone disease. We retrospectively reviewed the charts of 180 calcium oxalate stone formers who underwent non-contrast CT and 24-hour urine chemistry in our hospital between September 2012 and November 2021. Two observers independently measured the Hounsfield unit (HU) of the renal papilla and classified the patients into the low-HU and the high-HU value groups according to the median value (38.9 HU). The proportion of recurrent and multiple stone formers were similar between the low-HU group and the high-HU group (70.0% vs. 65.6%, 71.1% vs. 74.2%, respectively). There were also no significant differences in urinary volume, urinary excretions of each constituent, or AP(CaOx) index between the two groups. On the other hand, the recurrence rate in the high-HU value group (0.10 events/person/year) was significantly higher than that in the low-HU value group (0 events/person/year, p = 0.03). Multivariate analysis revealed that high-HU value was an independent predictor of stone recurrence (OR 1.90, 95% CI 1.00-3.64, p = 0.04) as well as medical prophylaxis. The results of this study suggest that HU value of renal papilla is a useful predictor of recurrence of stone disease.</p>","PeriodicalId":9285,"journal":{"name":"BMC Urology","volume":"24 1","pages":"279"},"PeriodicalIF":1.7000,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12894-024-01657-8","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
In calcium stone formers, most stones grow attached to Randall's plaque, which can be identified by measuring the computed tomography (CT) attenuation value of renal papilla. We hypothesized that the CT attenuation value of renal papilla can predict the severity (recurrent or multiple stone former) and recurrence of the stone disease. We retrospectively reviewed the charts of 180 calcium oxalate stone formers who underwent non-contrast CT and 24-hour urine chemistry in our hospital between September 2012 and November 2021. Two observers independently measured the Hounsfield unit (HU) of the renal papilla and classified the patients into the low-HU and the high-HU value groups according to the median value (38.9 HU). The proportion of recurrent and multiple stone formers were similar between the low-HU group and the high-HU group (70.0% vs. 65.6%, 71.1% vs. 74.2%, respectively). There were also no significant differences in urinary volume, urinary excretions of each constituent, or AP(CaOx) index between the two groups. On the other hand, the recurrence rate in the high-HU value group (0.10 events/person/year) was significantly higher than that in the low-HU value group (0 events/person/year, p = 0.03). Multivariate analysis revealed that high-HU value was an independent predictor of stone recurrence (OR 1.90, 95% CI 1.00-3.64, p = 0.04) as well as medical prophylaxis. The results of this study suggest that HU value of renal papilla is a useful predictor of recurrence of stone disease.
期刊介绍:
BMC Urology is an open access journal publishing original peer-reviewed research articles in all aspects of the prevention, diagnosis and management of urological disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
The journal considers manuscripts in the following broad subject-specific sections of urology:
Endourology and technology
Epidemiology and health outcomes
Pediatric urology
Pre-clinical and basic research
Reconstructive urology
Sexual function and fertility
Urological imaging
Urological oncology
Voiding dysfunction
Case reports.